Article
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.
EBioMedicine - 1 May 2023
Jimenez-Leon Maria R, Gasca-Capote Carmen, Tarancon-Diez Laura, Dominguez-Molina Beatriz, Lopez-Verdugo Macarena, Ritraj Ryan, Gallego Isabel, Alvarez-Rios Ana I, Vitalle Joana, Bachiller Sara, Camacho-Sojo María Inés, Perez-Gomez Alberto, Espinosa Nuria, Roca-Oporto Cristina, Rafii-El-Idrissi Benhnia Mohamed, Gutierrez-Valencia Alicia, Lopez-Cortes Luis F, Ruiz-Mateos Ezequiel
Abstract excerpt
BACKGROUND: Plasmacytoid dendritic cells (pDCs) sense viral and bacterial products through Toll-like receptor (TLR)-7 and -9 and translate this sensing into Interferon-α (IFN-α) production and T-cell activation. The understanding of the mechanisms involved in pDCs stimulation may contribute to HIV-cure immunotherapeutic strategies. The objective of the present study was to characterize the immunomodulatory...
Topics
- Toll-Like Receptor 9
- Dendritic Cells
- Cytokines
- Adjuvants, Immunologic
- Phenotype
